GSK signs £50m deal with Oxford University on cancer vaccines

Collaboration over at least three years aims to help understand how pre-cancerous cells developBusiness live – latest updatesGSK has said it will spend £50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers.The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop. Continue reading...

Jan 27, 2025 - 16:51
 0
GSK signs £50m deal with Oxford University on cancer vaccines

Collaboration over at least three years aims to help understand how pre-cancerous cells develop

GSK has said it will spend £50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers.

The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop. Continue reading...